Tobira Therapeutics (TBRA) Reports Q3 Loss of $1.22/Share

Tobira Therapeutics (NASDAQ: TBRA) reported Q3 EPS of ($1.22), versus ($7.29) reported last year.

For earnings history and earnings-related data on Tobira Therapeutics (TBRA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c